These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24515459)

  • 21. [A new approach to the design of hybrid hybridomas based on the use of an actinomycin D-resistant line of murine myeloma].
    Massino IuS; Kizim EA; Dmitriev AD
    Biull Eksp Biol Med; 1991 Nov; 112(11):511-4. PubMed ID: 1687361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening hybridomas for cell surface antigens by high-throughput homogeneous assay and flow cytometry.
    Uribe-Benninghoff A; Cabral T; Chronopoulou E; Berry JD; Corbett CR
    Methods Mol Biol; 2014; 1131():81-103. PubMed ID: 24515461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of Neutralizing Antibody.
    Takemasa E; Liu S; Hasegawa H
    Methods Mol Biol; 2018; 1868():79-92. PubMed ID: 30244456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and immunohistological characterization of monoclonal antibodies against rat ovarian antigens.
    Russinova AI; Hristov IP; Davidoff MS
    Exp Cell Res; 1994 Apr; 211(2):307-13. PubMed ID: 8143778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
    Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
    J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preparation and identification of monoclonal antibodies against Helicobacter pylori].
    Li Y; Ning YS; Hong YH; Liu YC; Luo J; Long M; Dong WQ; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):425-7. PubMed ID: 16624743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues.
    Danger Y; Gadjou C; Devys A; Galons H; Blanchard D; Folléa G
    J Immunol Methods; 2006 Feb; 309(1-2):1-10. PubMed ID: 16412457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hybridoma revolution: an offshoot of basic research.
    Milstein C
    Bioessays; 1999 Nov; 21(11):966-73. PubMed ID: 10517870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The development of methods for obtaining monoclonal antibody-producing cells].
    Skowicki M; Lipiński T
    Postepy Hig Med Dosw (Online); 2016 Apr; 70():367-79. PubMed ID: 27117113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and identification of monoclonal antibody against abrin-a.
    Li XB; Yang W; Zhang Y; Zhang ZG; Kong T; Li DN; Tang JJ; Liu L; Liu GW; Wang Z
    J Agric Food Chem; 2011 Sep; 59(18):9796-9. PubMed ID: 21870856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of rabbit monoclonal antibodies.
    Yam PC; Knight KL
    Methods Mol Biol; 2014; 1131():71-9. PubMed ID: 24515460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Updates on the Production of Therapeutic Antibodies Using Human Hybridoma Technique.
    Glukhova XA; Prusakova OV; Trizna JA; Zaripov MM; Afanas'eva GV; Glukhov AS; Poltavtseva RA; Ivanov AA; Avila-Rodriguez M; Barreto GE; Aliev G; Beletsky IP
    Curr Pharm Des; 2016; 22(7):870-8. PubMed ID: 26696411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal Antibodies Generation: Updates and Protocols on Hybridoma Technology.
    Muhsin A; Rangel R; Vien L; Bover L
    Methods Mol Biol; 2022; 2435():73-93. PubMed ID: 34993940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current state of the hybridoma technology.
    Pirofski L; Casadevall A; Rodriguez L; Zuckier LS; Scharff MD
    J Clin Immunol; 1990 Nov; 10(6 Suppl):5S-12S; discussion 12S-14S. PubMed ID: 2081790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.
    Parray HA; Shukla S; Samal S; Shrivastava T; Ahmed S; Sharma C; Kumar R
    Int Immunopharmacol; 2020 Aug; 85():106639. PubMed ID: 32473573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Industrial implementation of in vitro production of monoclonal antibodies.
    Dewar V; Voet P; Denamur F; Smal J
    ILAR J; 2005; 46(3):307-13. PubMed ID: 15953838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress in preparation of small monoclonal antibodies of knock out technique].
    Liu J; Mao XM; Li LL; Li XX; Wang Y; Lan Y
    Zhongguo Zhong Yao Za Zhi; 2015 Oct; 40(19):3737-41. PubMed ID: 26975094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies.
    Singh R; Chandley P; Rohatgi S
    Immunohorizons; 2023 Dec; 7(12):886-897. PubMed ID: 38149884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.